Skip to main content

5'-Triphosphate guanosine RNAs recruit GTP-binding proteins to suppress RIG-I/IFN type I signaling.

Molecular cell

Authors: Magdalena Wolczyk, Jacek Szymanski, Ivan Trus, Zara Naz, Nathalie Idlin, Michal Lechowski, Emilia Baranowska, Alicja Bis, Jakub Stanislaw Nowak, Tola Tame, Justyna Jackiewicz, Elzbieta Nowak, Christine Wuebben, Gunther Hartmann, Juri Rappsilber, Gracjan Michlewski

The interferon (IFN) response is crucial for antiviral activity, but excessive activation can contribute to tissue damage and autoimmune disorders. The cytoplasmic receptor retinoic acid-inducible gene I (RIG-I) detects viral double-stranded RNAs (dsRNAs) and endogenous RNA polymerase III (RNA Pol III) transcripts carrying a 5'-triphosphate (5'-ppp) moiety, triggering IRF3 phosphorylation and IFN response. Many viral RNAs initiate with 5'-triphosphate adenosine (5'-pppA), whereas most endogenous RNA Pol III transcripts in higher eukaryotes start with 5'-triphosphate guanosine (5'-pppG), yet no reason for this bias is known. Here, we show that 5'-pppA dsRNAs trigger stronger RIG-I/IFN responses than 5'-pppG dsRNAs, despite comparable RIG-I stimulation in vitro. Using RNA pull-down and mass spectrometry, we identify GTP-binding proteins that preferentially interact with 5'-pppG dsRNAs. Guanosine supplementation, which increases intracellular GTP levels, decreases the immunogenic difference between 5'-pppG and 5'-pppA dsRNAs. Our findings provide insights into sequence-dependent activation of the RIG-I/IFN pathway, with implications for evolutionary pressures on RNA sequences, RNA-driven autoimmunity, viral immunogenicity, and the rational design of RNA therapeutics.

Copyright © 2026 The Author(s). Published by Elsevier Inc. All rights reserved.

PMID: 42105765

Participating cluster members